Amiloride-enhanced gene transfection of octa-arginine functionalized calcium phosphate nanoparticles

PLoS One. 2017 Nov 16;12(11):e0188347. doi: 10.1371/journal.pone.0188347. eCollection 2017.

Abstract

Nanoparticles represent promising gene delivery systems in biomedicine to facilitate prolonged gene expression with low toxicity compared to viral vectors. Specifically, nanoparticles of calcium phosphate (nCaP), the main inorganic component of human bone, exhibit high biocompatibility and good biodegradability and have been reported to have high affinity for protein or DNA, having thus been used as gene transfer vectors. On the other hand, Octa-arginine (R8), which has a high permeability to cell membrane, has been reported to improve intracellular delivery systems. Here, we present an optimized method for nCaP-mediated gene delivery using an octa-arginine (R8)-functionalized nCaP vector containing a marker or functional gene construct. nCaP particle size was between 220-580 nm in diameter and all R8-functionalized nCaPs carried a positive charge. R8 concentration significantly improved nCaP transfection efficiency with high cell compatibility in human mesenchymal stem cells (hMSC) and human osteoblasts (hOB) in particular, suggesting nCaPs as a good option for non-viral vector gene delivery. Furthermore, pre-treatment with different endocytosis inhibitors identified that the endocytic pathway differed among cell lines and functionalized nanoparticles, with amiloride increasing transfection efficiency of R8-functionalized nCaPs in hMSC and hOB.

MeSH terms

  • Amiloride / pharmacology*
  • Arginine / chemistry*
  • Calcium Phosphates / chemistry*
  • HeLa Cells
  • Humans
  • Mesenchymal Stem Cells / cytology
  • Nanoparticles / chemistry*
  • Transfection*

Substances

  • Calcium Phosphates
  • Amiloride
  • Arginine
  • calcium phosphate

Grants and funding

This work was financially supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science. Grant No.: 26861667, (http://www.jsps.go.jp/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.